References
- Acheson E. D. The impending crisis of old age: a challenge to ingenuity. Lancet 1982; 2: 592–594
- Jones S. E., Fuks Z., Bull M., et al. Non-Hodgkin's lymphomas IV. Clinimpathologic correlation in 405 cases. Cancer 1973; 31: 5306–823
- Patchefsky A. S., Brodovsky H. S., Menduke H., et al. Non-Hodgkin's lymphomas: A clinicopathologic study of 293 cases. Cancer 1974; 34: 1173–1186
- Natwani B. N., Kim H., Rappaport H., et al. Non-Hodgkins's lymphomas. A clinicopathologic study compating two classifications. Cancer 1978; 41: 303–313
- Anderson T., Chabner B. A., Young R. C., et al. Malignant lymphoma I. The history of staging of 473 patients at the National Cancer Institute. Cancer 1982; 50: 2693–2707
- Carbone A., Tirelli U., Volpe R., et al. Non Hodgkm's lymphoma in the elderly: a retrospective clinimpathologic study of 56 patients. Cancer 1986; 57: 2185–2189
- Tmlli U., Zagonel V., Serraino D., et al. Non-Hodgkin's lymphomas in 137 patients aged 70 years or older: a retrospective european organization for researdl and treatment of cancer lymphoma group Study. J Clin Oncol 1988; 6(11)1708–1713
- Marotla G., Soh R., Gattei V., et al. High frequency of cross-lineage antigenic expression in acute leukaemia cells of elderly patients. Bone Marrow Transpl 1989; 4(3)20, (ii)
- Armitage J. O., Potter J. F. Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly: increased complications with advancing age. J Am Geriatr Soc 1984; 32: 269–273
- Tirelli U., Carbone A., Crivellari D., et al. A phase II trial of teniposide (VM 26) in advanced non-Hodgkin's lymphoma, with emphasis on the treatment of elderly patients. Cancer 1984; 54: 393–396
- Mäkansson L., Konyves I., Ludwig L., et al. Combination treatment of non-Hodgkin's malignant lymphoma with prednimustine (LEO 1031). Oncology 1978; 35: 103–106
- Miller A. B., Hoogstraten B., Staquet M., et al. Reporting results of cancer treatment. Cancer 1981; 47: 201–214
- Peto R., Pike M. C., Armitage P., et al. Design and analysis on randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1983; 52: 1986–1992
- Samet J., Hunt W. C., Key C., et al. Choice of cancer therapy varies with age of patient. J Am Med Assoc 1986; 255: 3385–3390
- Sweetenham J., Williams C. Malignant lymphoma in the elderly. Baillière's Clin Haematol 1987; 1(2)493–511
- Zagonel V., Tirelli U., Carbone A. Treatment of non-Hodglun's lymphoma in the elderly. J Clin Oncol 1986; 12: 1866–1867
- Dixon D. O., Neilan B., Jones S. E., et al. Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group Experience. J Clin Oncol 1986; 3: 295–305
- O'Connel M. J., Earle J. D., Hanhgton D. P., et al. Initial chemotherapy doses for elderly patients with malignant lymphoma. J Clin Oncol 1986; 9: 1418
- Miller T. P., Jones S. E. Initial chemotherapy for clinically localized lymphomas of unfavourable histology. Blood 1983; 62: 413–418
- Zagonel V., Tirelli U. Age as a risk factor for inadequate treatment. JAMA 1988; 259(1)41